Recent Finacing
Recent Raise
Nafipharma develops nasal‑to‑brain delivery technologies and CNS therapeutics, operating Purenano nanomedicine platform, RA‑IDDS dosing devices, targeted olfactory‑zone spray tech, and a preclinical translational R&D pipeline.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor